Anja Lautem

Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma

Chirag Nepal, Colm J. O’Rourke, Douglas V.N.P. Oliveira et al. · Hepatology · 2017 · 138 citations · Full text

Medicine, Genetics, Oncology +17

Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance

Michael Heise, Anja Lautem, Johanna Knapstein et al. · BMC Cancer · 2012 · 109 citations · Full text

Medicine, Oncology, Pharmacology +13

Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma

Anja Lautem, Michael Heise, ANDREAS GRÄSEL et al. · International Journal of Oncology · 2013 · 50 citations · Full text

Medicine, Cancer Biology, Oncology +16

Liver Transplantation for Hepatocellular Carcinoma – Is There a Risk of Recurrence Caused by Intraoperative Blood Salvage Autotransfusion?

Daniel Foltys, Thomas Zimmermann, Michael Heise et al. · European Surgical Research · 2011 · 45 citations

Medicine, Oncology, Surgery +14

Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment

Daniela Grimm, Jonas Lieb, Veronika Weyer et al. · BMC Cancer · 2016 · 42 citations · Full text

Medicine, Oncology, Pharmacology +16